You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ifosfamide

Showing 26 - 50 of 560
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CNS Lymphoma Trial in Aarhus (Immunochemo)

Completed
  • Central Nervous System Lymphoma
  • Aarhus, Denmark
    Elisa Jacobsen Pulczynski
Aug 3, 2022

Sarcoma, Soft Tissue Trial in Worldwide (Nintedanib, Ifosfamide)

Terminated
  • Sarcoma, Soft Tissue
  • Brussels, Belgium
  • +12 more
Sep 10, 2021

Relapsed Diffuse Large B-cell Lymphoma, Refractory DLBCL Trial in Worldwide (Polatuzumab Vedotin, Mabthera, Ifosfamide)

Recruiting
  • Relapsed Diffuse Large B-cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Polatuzumab Vedotin
  • +4 more
  • Graz, Austria
  • +62 more
Aug 2, 2022

Diffuse Large B Cell Lymphoma Trial (Pembrolizumab, Rituximab, Ifosfamide)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Headington, Oxford, United Kingdom
  • +1 more
Nov 2, 2022

Peripheral T-cell Lymphoma Trial in Singapore (Selinexor, ICE Chemotherapy)

Completed
  • Peripheral T-cell Lymphoma
  • Singapore, Singapore
    National Cancer Centre Singapore
Apr 27, 2021

Sarcoma Trial in Baltimore, Minneapolis (biological, drug, procedure, radiation)

Active, not recruiting
  • Sarcoma
  • pegfilgrastim
  • +5 more
  • Baltimore, Maryland
  • +1 more
Mar 25, 2022

Effect of Drug, Toxicity, Drug Trial in Beijing (apatinib)

Recruiting
  • Effect of Drug
  • Toxicity, Drug
  • Beijing, Beijing, China
  • +1 more
Jul 12, 2021

Retroperitoneal Sarcoma Trial in China (Doxorubicin+Ifosfamide+Anlotinib(AI+A), Radical Surgery)

Enrolling by invitation
  • Retroperitoneal Sarcoma
  • Beijing, Beijing, China
  • +5 more
May 11, 2023

Burkitt's Lymphoma, Burkitt's Leukemia, Mediastinal Tumors Trial in Frankfurt (Adriamycin, Cyclophosphamide, Cytarabine)

Completed
  • Burkitt's Lymphoma
  • +4 more
  • Frankfurt, Germany
    University Hospital, Medical Dept. II
Aug 17, 2022

CD20 Positive, Recurrent DLBCL, Refractory DLBCL Trial in Buffalo (drug, other, biological)

Active, not recruiting
Has Results
  • CD20 Positive
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 11, 2021

Soft Tissue Sarcoma Trial in Bordeaux, Montpellier, Toulouse (Patients starting a treatment with Doxorubicin and Ifosfamide)

Completed
  • Soft Tissue Sarcoma
  • Patients starting a treatment with Doxorubicin and Ifosfamide
  • Bordeaux, France
  • +2 more
Jan 11, 2021

Mantle-Cell Lymphoma Trial in Miami (G-CSF, Rituximab, Cyclophosphamide)

Active, not recruiting
  • Mantle-Cell Lymphoma
  • G-CSF
  • +10 more
  • Miami, Florida
    University of Miami
Aug 12, 2021

NSCLC Trial in Seoul (Durvalumab + doxorubicin + ifosfamide)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Durvalumab + doxorubicin + ifosfamide
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Nov 30, 2020

Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults Trial in Italy, Spain (epirubicin 60

Active, not recruiting
  • Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults
  • epirubicin 60 mg/m2/day (days 1, 2) and ifosfamide 3 g/m2/day (days 1, 2, 3)
  • +5 more
  • Candiolo, TO, Italy
  • +14 more
Nov 15, 2021

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Trial

Active, not recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Jacksonville, Florida
  • +11 more
Jan 12, 2023

DLBCL Unclassifiable, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Trial in Duarte,

Recruiting
  • Diffuse Large B-Cell Lymphoma Unclassifiable
  • +6 more
  • Duarte, California
  • +1 more
Oct 1, 2021

Intracranial Germ Cell CNS Tumor, Childhood Trial in Beijing (radiation, drug, procedure)

Recruiting
  • Intracranial Germ Cell CNS Tumor, Childhood
  • Whole-ventricle irradiation
  • +3 more
  • Beijing, China
    Beijing Tiantan Hospital
Nov 7, 2021

Extracranial Germ Cell Tumor, Pediatric Trial (albumin-bound paclitaxel (nab-PTX), ifosfamide and cisplatin)

Not yet recruiting
  • Extracranial Germ Cell Tumor, Pediatric
  • albumin-bound paclitaxel (nab-PTX), ifosfamide and cisplatin
  • (no location specified)
Oct 6, 2020

Ewing's Sarcoma Trial in Italy (Standard treatment (as per protocol ISG SSG III), Intensified chemo)

Active, not recruiting
  • Ewing's Sarcoma
  • Standard treatment (as per protocol ISG SSG III)
  • Intensified chemotherapy
  • Aviano, Pordenone, Italy
  • +13 more
Oct 29, 2021

Advanced Solid Tumors Trial in China (MASCT-I, Ifosfamide, PD1 antibody)

Recruiting
  • Advanced Solid Tumors
  • MASCT-I
  • +6 more
  • Beijing, Beijing, China
  • +8 more
Dec 29, 2022

Osteosarcoma Trial in Italy (Mifamurtide arm, 3 drugs arm)

Active, not recruiting
  • Osteosarcoma
  • Mifamurtide arm
  • 3 drugs arm
  • Candiolo, Torino, Italy
  • +10 more
Sep 16, 2022

NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma Trial in San Francisco, Valhalla (Methotrexate, pralatraxate,,

Recruiting
  • NK-Cell Lymphoma
  • +2 more
  • San Francisco, California
  • +1 more
Sep 1, 2021

Unresectable Sinonasal Tumors Trial in Italy (Cisplatin, Docetaxel, 5-fluorouracil)

Active, not recruiting
  • Unresectable Sinonasal Tumors
  • Brescia, BS, Italy
  • +4 more
Apr 8, 2022

Sinonasal Tumors Trial in Italy (Cisplatin, Docetaxel, 5-fluorouracil)

Active, not recruiting
  • Sinonasal Tumors
  • Brescia, BS, Italy
  • +4 more
Apr 8, 2022

Hodgkin's Lymphoma Trial in Houston (Panobinostat, Ifosfamide, Mesna)

Completed
Has Results
  • Hodgkin's Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 10, 2020